# ASTM F1980 Updates and Changes That Impact Medical Packaging

> Stay current on ASTM F1980 updates and changes, and how they impact sterile packaging validation and shelf-life claims.

Source: https://lso-inc.com/news/updates-to-astm-f1980/

---

NewsMarch 13, 2025

# What Are the Latest Updates to ASTM F1980 for Accelerated Aging?

![accelerated-aging-chamber](https://lso-inc.com/api/media/file/accelerated-aging-chamber-3.png)

**Editor's Note:** This article discusses historical updates to ASTM F1980. For the current standard overview, see [Official ASTM F1980 Accelerated Aging Standard Overview](https://lso-inc.com/medical-package-testing/standards/astm-f-standards/astm-f1980/).

Recent revisions to ASTM F1980 clarified requirements related to accelerated aging calculations and documentation expectations. Medical device manufacturers rely on [**ASTM F1980**](https://lso-inc.com/medical-package-testing/standards/astm-f-standards/astm-f1980/), the standard guide for accelerated aging of sterile medical packaging, to predict real-time shelf-life and ensure compliance with regulatory expectations. As technology evolves and regulatory scrutiny increases, **ASTM F1980 continues to be updated** to enhance testing accuracy and reliability.

If you’re wondering **what the latest changes to ASTM F1980 mean for your packaging validation**, this article provides a breakdown of the most significant updates and how they impact medical device manufacturers.

## Context for the Latest ASTM F1980 Updates

ASTM F1980 is the recognized standard for accelerated aging of sterile medical device packaging. A full technical overview of the standard is available in our [**ASTM F1980 Accelerated Aging Standard Overview**](https://lso-inc.com/medical-package-testing/standards/astm-f-standards/astm-f1980/).

This article focuses specifically on **what has changed**, why those changes were made, and how they impact accelerated aging studies already in progress or under development.

## **Key Updates in the Latest ASTM F1980 Revision**

Recent updates to **ASTM F1980** have introduced several refinements to improve the accuracy and applicability of accelerated aging studies. The most notable changes include:

1.  **Clarification on Temperature Selection and Test Conditions**

-   The latest revision emphasizes that **temperature selection must be justified** based on material stability rather than arbitrary elevated levels.
-   The guide provides more **specific criteria for selecting aging temperatures** to prevent unrealistic degradation or material failures.

1.  **Consideration of Humidity as a Factor**

-   Traditionally, ASTM F1980 focused primarily on temperature, but new guidance encourages manufacturers to **evaluate the role of humidity** in accelerated aging studies.
-   This change aligns with industry trends recognizing that **moisture-sensitive materials** may degrade differently under combined heat and humidity exposure.

1.  **Enhanced Guidance on Real-Time Aging Correlation**

-   New language in the standard reinforces that accelerated aging **does not replace real-time aging studies** but should be used to supplement them.
-   Manufacturers are encouraged to **correlate accelerated aging results with real-time data** whenever possible to validate their findings.

1.  **Expansion of Material-Specific Considerations**

-   The revised standard **highlights the importance of material-specific evaluations** when applying the Arrhenius model.
-   **Polymer degradation, seal integrity, and sterile barrier system performance** must be assessed with a more tailored approach rather than a one-size-fits-all aging model.

1.  **Risk-Based Approach to Aging Studies**

-   The updated ASTM F1980 includes a **risk-based framework** for selecting test conditions.
-   Manufacturers are expected to assess the **criticality of the device, expected storage conditions, and potential failure modes** before determining test parameters.

## **What Do These Changes Mean for Medical Device Manufacturers?**

These updates emphasize a more **scientific, risk-based approach** to accelerated aging, ensuring that results are both **reliable and representative** of real-world conditions. Medical device manufacturers should take the following actions in response to the latest ASTM F1980 changes:

-   **Review existing accelerated aging protocols** to ensure they align with the latest guidance.
-   **Justify temperature selections** with material data rather than arbitrary choices.
-   **Consider incorporating humidity testing** for materials sensitive to moisture exposure.
-   **Strengthen correlations between accelerated and real-time aging data** to improve regulatory compliance.
-   **Document a risk-based rationale** for accelerated aging conditions to support audits and regulatory reviews.

## **How LSO Can Help**

At LSO, we specialize in **medical packaging validation, including accelerated aging studies** in compliance with ASTM F1980. Our team of experts can help you:

-   Design **custom accelerated aging protocols** tailored to your device and packaging materials.
-   Perform [**real-time and accelerated aging**](https://lso-inc.com/services/medical-package-testing/services/accelerated-real-time-aging/) **correlation studies** for stronger validation.
-   Provide regulatory **documentation support** to meet FDA, EU MDR, and ISO 11607 requirements.

## **Conclusion**

The latest updates to ASTM F1980 reinforce the need for **scientific justification, material-specific considerations, and risk-based validation** in accelerated aging studies. By adapting to these changes, medical device manufacturers can ensure their packaging remains **compliant, reliable, and ready for regulatory scrutiny**.

If you have questions about [ASTM F1980](https://lso-inc.com/medical-package-testing/standards/astm-f-standards/astm-f1980/) or need assistance with your aging studies, [**reach out to LSO**](https://lso-inc.com/contact/) today for expert guidance on packaging validation.

## Related Articles

[Jan 29, 2026

### What the FDA’s QMSR Means for Medical Device OEMs and Manufacturing Partners

Read Article](https://lso-inc.com/news/fda-qmsr-what-it-means-for-oems/) [Dec 19, 2025

### ASTM D4169 Schedule E: Random Vibration Testing

Read Article](https://lso-inc.com/news/astm-d4169-schedule-e/) [Dec 19, 2025

### ASTM D4169 Schedule I: Low Pressure (Vacuum) Testing

Read Article](https://lso-inc.com/news/astm-d4169-schedule-i/)

## Ship faster with fewer vendors

LSO consolidates assembly, packaging, validation, and sterilization under one roof — FDA-registered, ISO 13485-certified, across three facilities. Tell us about your device and we'll map the fastest path to production.

[Request a Quote](https://lso-inc.com/contact/)

Or call us directly: [(714) 672-1090](tel:7146721090)
